Sunshine Biopharma, Inc.
SBFM
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.03M | 6.98M | 9.12M | 9.31M | 10.31M |
| Total Receivables | 4.04M | 4.01M | 3.46M | 4.16M | 3.59M |
| Inventory | 12.12M | 13.17M | 13.47M | 14.06M | 13.02M |
| Prepaid Expenses | 478.50K | 618.40K | 798.40K | 441.50K | 939.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 30.67M | 24.78M | 26.85M | 27.97M | 27.85M |
|
|
|||||
| Total Current Assets | 30.67M | 24.78M | 26.85M | 27.97M | 27.85M |
| Net Property, Plant & Equipment | 1.13M | 1.23M | 1.34M | 1.42M | 1.53M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.84M | 1.92M | 1.89M | 2.01M | 2.49M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 92.20K | 92.20K |
| Total Assets | 33.63M | 27.93M | 30.08M | 31.49M | 31.97M |
|
|
|||||
| Total Accounts Payable | 4.85M | 5.10M | 5.66M | 6.14M | 4.80M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 202.50K | 209.20K | 215.60K | 218.10K | 222.50K |
| Total Finance Division Other Current Liabilities | 564.10K | 564.10K | 564.10K | 295.80K | 554.00K |
| Total Other Current Liabilities | 564.10K | 564.10K | 564.10K | 295.80K | 554.00K |
| Total Current Liabilities | 5.62M | 5.88M | 6.44M | 6.65M | 5.57M |
|
|
|||||
| Total Current Liabilities | 5.62M | 5.88M | 6.44M | 6.65M | 5.57M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 475.80K | 535.60K | 596.80K | 636.70K | 706.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.09M | 6.41M | 7.04M | 7.29M | 6.28M |
|
|
|||||
| Common Stock & APIC | 106.01M | 98.11M | 98.11M | 97.38M | 97.38M |
| Retained Earnings | -77.82M | -76.26M | -75.02M | -72.87M | -71.99M |
| Treasury Stock & Other | -658.90K | -343.30K | -65.30K | -320.80K | 280.80K |
| Total Common Equity | 27.53M | 21.50M | 23.03M | 24.19M | 25.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 13.00K | 13.00K | 13.00K | 13.00K | 13.00K |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 13.00K | 13.00K | 13.00K | 13.00K | 13.00K |
|
|
|||||
| Total Common Equity | 27.53M | 21.50M | 23.03M | 24.19M | 25.67M |
| Total Preferred Equity | 13.00K | 13.00K | 13.00K | 13.00K | 13.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 27.54M | 21.52M | 23.04M | 24.20M | 25.68M |
|
|
|||||